{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:06:12Z","timestamp":1779955572906,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Supported by the Special Research Fund for Central Universities, Peking Union Medical College","award":["3332023024"],"award-info":[{"award-number":["3332023024"]}]},{"name":"Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2021B20"],"award-info":[{"award-number":["LC2021B20"]}]},{"name":"National High Level Hospital Clinical Research Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00535-026-02348-x","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:02:10Z","timestamp":1769749330000},"page":"808-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study"],"prefix":"10.1007","volume":"61","author":[{"given":"Hu","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-2694","authenticated-orcid":false,"given":"Dongbing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"3","key":"2348_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2348_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"key":"2348_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","volume":"520","author":"J Cai","year":"2021","unstructured":"Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.027.","journal-title":"Cancer Lett"},{"key":"2348_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682969","volume":"11","author":"H Li","year":"2021","unstructured":"Li H, Zhou F, Cao Z, et al. Development and validation of a nomogram based on nutritional indicato rs and tumor markers for prognosis prediction of pancreatic ductal ade nocarcinoma. Front Oncol. 2021;11:682969. https:\/\/doi.org\/10.3389\/fonc.2021.682969.","journal-title":"Front Oncol"},{"issue":"1","key":"2348_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08943-w","volume":"21","author":"GC Deng","year":"2021","unstructured":"Deng GC, Lv Y, Yan H, et al. Nomogram to predict survival of patients with advanced and metastatic pancreatic cancer. BMC Cancer. 2021;21(1):1227. https:\/\/doi.org\/10.1186\/s12885-021-08943-w.","journal-title":"BMC Cancer"},{"issue":"1","key":"2348_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s41747-019-0119-0","volume":"3","author":"G Kaissis","year":"2019","unstructured":"Kaissis G, Ziegelmayer S, Loh\u00f6fer F, et al. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging. Eur Radiol Exp. 2019;3(1):41. https:\/\/doi.org\/10.1186\/s41747-019-0119-0.","journal-title":"Eur Radiol Exp"},{"key":"2348_CR7","doi-asserted-by":"publisher","DOI":"10.1159\/000540329","author":"JY Tang","year":"2024","unstructured":"Tang JY, Kouznetsova VL, Kesari S, et al. Development of a diagnostic model for pancreatic ductal adenocarcinoma using machine learning and blood-based miRNAs. Oncology. 2024. https:\/\/doi.org\/10.1159\/000540329. ((published Online First: 20240904)).","journal-title":"Oncology"},{"key":"2348_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.895515","volume":"12","author":"J Chang","year":"2022","unstructured":"Chang J, Liu Y, Saey SA, et al. Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma. Front Oncol. 2022;12:895515. https:\/\/doi.org\/10.3389\/fonc.2022.895515.","journal-title":"Front Oncol"},{"key":"2348_CR9","unstructured":"Lundberg S. A unified approach to interpreting model predictions. 2017. arXiv:170507874."},{"issue":"1","key":"2348_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2020.03.022","volume":"181","author":"J Goecks","year":"2020","unstructured":"Goecks J, Jalili V, Heiser LM, et al. How machine learning will transform biomedicine. Cell. 2020;181(1):92\u2013101. https:\/\/doi.org\/10.1016\/j.cell.2020.03.022.","journal-title":"Cell"},{"key":"2348_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1488118","volume":"14","author":"B Teng","year":"2024","unstructured":"Teng B, Zhang X, Ge M, et al. Personalized three-year survival prediction and prognosis forecast by interpretable machine learning for pancreatic cancer patients: a population-based study and an external validation. Front Oncol. 2024;14:1488118. https:\/\/doi.org\/10.3389\/fonc.2024.1488118.","journal-title":"Front Oncol"},{"issue":"3","key":"2348_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.pan.2020.01.012","volume":"20","author":"A Exarchakou","year":"2020","unstructured":"Exarchakou A, Papacleovoulou G, Rous B, et al. Pancreatic cancer incidence and survival and the role of specialist ce ntres in resection rates in England, 2000 to 2014: a population-based study. Pancreatology. 2020;20(3):454\u201361. https:\/\/doi.org\/10.1016\/j.pan.2020.01.012.","journal-title":"Pancreatology"},{"issue":"3","key":"2348_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jncc.2024.06.005","volume":"4","author":"H Zeng","year":"2024","unstructured":"Zeng H, Zheng R, Sun K, et al. Cancer survival statistics in China 2019-2021: a multicenter, population-based study. J Natl Cancer Cent. 2024;4(3):203\u201313. https:\/\/doi.org\/10.1016\/j.jncc.2024.06.005.","journal-title":"J Natl Cancer Cent"},{"issue":"5","key":"2348_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249911","volume":"16","author":"R Zhong","year":"2021","unstructured":"Zhong R, Jiang X, Peng Y, et al. A nomogram prediction of overall survival based on lymph node ratio, A jcc 8th staging system, and other factors for primary pancreatic cance r. PLoS One. 2021;16(5):e0249911. https:\/\/doi.org\/10.1371\/journal.pone.0249911.","journal-title":"PLoS One"},{"issue":"1","key":"2348_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10908-0","volume":"23","author":"P Yunpeng","year":"2023","unstructured":"Yunpeng P, Lingdi Y, Xiaole Z, et al. Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer. BMC Cancer. 2023;23(1):548. https:\/\/doi.org\/10.1186\/s12885-023-10908-0.","journal-title":"BMC Cancer"},{"issue":"9","key":"2348_CR16","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1245\/s10434-010-1071-7","volume":"17","author":"N Wasif","year":"2010","unstructured":"Wasif N, Ko CY, Farrell J, et al. Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol. 2010;17(9):2312\u201320. https:\/\/doi.org\/10.1245\/s10434-010-1071-7.","journal-title":"Ann Surg Oncol"},{"key":"2348_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092367","author":"M Felsenstein","year":"2022","unstructured":"Felsenstein M, Lindhammer F, Feist M, et al. Perineural invasion in pancreatic ductal adenocarcinoma (PDAC): a saboteur of curative intended therapies? J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11092367.","journal-title":"J Clin Med"},{"key":"2348_CR18","doi-asserted-by":"publisher","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a s ystematic review and meta-analysis. JNCI.https:\/\/doi.org\/10.1093\/jnci\/dju124.","DOI":"10.1093\/jnci\/dju124"},{"key":"2348_CR19","doi-asserted-by":"publisher","unstructured":"van der Gaag NA, Rauws EAJ, van Eijck CHJ, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 362(2):129\u201337. https:\/\/doi.org\/10.1056\/nejmoa0903230.","DOI":"10.1056\/nejmoa0903230"},{"issue":"4","key":"2348_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ejso.2011.12.020","volume":"38","author":"SM Robinson","year":"2012","unstructured":"Robinson SM, Rahman A, Haugk B, et al. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2012;38(4):333\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2011.12.020.","journal-title":"Eur J Surg Oncol"},{"key":"2348_CR21","first-page":"79","volume":"37","author":"H Dur\u00e1n","year":"2020","unstructured":"Dur\u00e1n H, Olivares S, Ielpo B, et al. Prognostic value of lymph node status for actual long-term survival in resected pancreatic cancer. Surg Technol Int. 2020;37:79\u201384.","journal-title":"Surg Technol Int"},{"issue":"Suppl 1","key":"2348_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ijsu.2015.06.050[publishedOnlineFirst:20150626]","volume":"21","author":"G Benassai","year":"2015","unstructured":"Benassai G, Quarto G, Perrotta S, et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma\u2014surgical treatment. Int J Surg. 2015;21(Suppl 1):S1-3. https:\/\/doi.org\/10.1016\/j.ijsu.2015.06.050[publishedOnlineFirst:20150626].","journal-title":"Int J Surg"},{"issue":"9","key":"2348_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/jhbp.1159","volume":"29","author":"SK Min","year":"2022","unstructured":"Min SK, You Y, Choi DW, et al. Prognosis of pancreatic head cancer with different patterns of lymph n ode metastasis. J Hepatobiliary Pancreat Sci. 2022;29(9):1004\u201313. https:\/\/doi.org\/10.1002\/jhbp.1159.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"2348_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/sla.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot VP, Gemenetzis G, Blair AB, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(6):1154\u201362. https:\/\/doi.org\/10.1097\/sla.0000000000002734.","journal-title":"Ann Surg"},{"issue":"2","key":"2348_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11255-019-02300-4","volume":"52","author":"C Chen","year":"2020","unstructured":"Chen C, Shen J, Xing Z, et al. Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study. Int Urol Nephrol. 2020;52(2):271\u20138. https:\/\/doi.org\/10.1007\/s11255-019-02300-4.","journal-title":"Int Urol Nephrol"},{"key":"2348_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.752176","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Ji L, Wang X, et al. Nomogram predicts risk and prognostic factors for bone metastasis of pancreatic cancer: a population-based analysis. Front Endocrinol (Lausanne). 2021;12:752176. https:\/\/doi.org\/10.3389\/fendo.2021.752176.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2348_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/0284186x.2021.2016949","volume":"61","author":"JC van Dongen","year":"2022","unstructured":"van Dongen JC, van der Geest LGM, de Meijer VE, et al. Age and prognosis in patients with pancreatic cancer: a population-based study. Acta Oncol. 2022;61(3):286\u201393. https:\/\/doi.org\/10.1080\/0284186x.2021.2016949.","journal-title":"Acta Oncol"},{"issue":"8","key":"2348_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1158\/0008-5472.Can-24-0086","volume":"84","author":"DJ Zabransky","year":"2024","unstructured":"Zabransky DJ, Chhabra Y, Fane ME, et al. Fibroblasts in the aged pancreas drive pancreatic cancer progression. Cancer Res. 2024;84(8):1221\u201336. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-0086.","journal-title":"Cancer Res"},{"issue":"6","key":"2348_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00280-020-04165-2","volume":"86","author":"C Ye","year":"2020","unstructured":"Ye C, Sadula A, Ren S, et al. The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis. Cancer Chemother Pharmacol. 2020;86(6):731\u201340. https:\/\/doi.org\/10.1007\/s00280-020-04165-2.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"20","key":"2348_CR30","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1097\/CM9.0000000000003130","volume":"137","author":"D Zhang","year":"2024","unstructured":"Zhang D, Cui F, Zheng K, et al. Single-cell RNA sequencing reveals the process of CA19-9 production an d dynamics of the immune microenvironment between CA19-9 (+) and CA19- 9 (-) PDAC. Chin Med J. 2024;137(20):2415\u201328. https:\/\/doi.org\/10.1097\/CM9.0000000000003130.","journal-title":"Chin Med J"},{"key":"2348_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184594","author":"J Wang","year":"2021","unstructured":"Wang J, Chen Y, Li X, et al. Perineural invasion and associated pain transmission in pancreatic cancer. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13184594.","journal-title":"Cancers (Basel)"},{"key":"2348_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215863","volume":"546","author":"Z Tian","year":"2022","unstructured":"Tian Z, Ou G, Su M, et al. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Cancer Lett. 2022;546:215863. https:\/\/doi.org\/10.1016\/j.canlet.2022.215863.","journal-title":"Cancer Lett"},{"issue":"18","key":"2348_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184594","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang J, Chen Y, Li X, et al. Perineural invasion and associated pain transmission in pancreatic can cer. Cancers. 2021;13(18):4594. https:\/\/doi.org\/10.3390\/cancers13184594.","journal-title":"Cancers"},{"key":"2348_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, Sugawara T, Karam SD, et al. Advances in the management of pancreatic cancer. BMJ. 2023;383:e073995. https:\/\/doi.org\/10.1136\/bmj-2022-073995.","journal-title":"BMJ"},{"issue":"14","key":"2348_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310(14):1473\u201381. https:\/\/doi.org\/10.1001\/jama.2013.279201.","journal-title":"JAMA"},{"issue":"2","key":"2348_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/jjco\/hyy190","volume":"49","author":"F Motoi","year":"2019","unstructured":"Motoi F, Kosuge T, Ueno H, et al. Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05). Jpn J Clin Oncol. 2019;49(2):190\u20134. https:\/\/doi.org\/10.1093\/jjco\/hyy190.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"2348_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s2468-1253(23)00405-3","volume":"9","author":"KJ Labori","year":"2024","unstructured":"Labori KJ, Bratlie SO, Andersson B, et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024;9(3):205\u201317. https:\/\/doi.org\/10.1016\/s2468-1253(23)00405-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"2348_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/mpa.0000000000001338","volume":"48","author":"G Luo","year":"2019","unstructured":"Luo G, Fan Z, Gong Y, et al. Characteristics and outcomes of pancreatic cancer by histological subtypes. Pancreas. 2019;48(6):817\u201322. https:\/\/doi.org\/10.1097\/mpa.0000000000001338.","journal-title":"Pancreas"},{"issue":"7","key":"2348_CR39","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1245\/s10434-020-09446-x","volume":"28","author":"MA Adam","year":"2021","unstructured":"Adam MA, Nassour I, Hoehn R, et al. Neoadjuvant chemotherapy for pancreatic adenocarcinoma lessens the deleterious effect of omission of adjuvant chemotherapy. Ann Surg Oncol. 2021;28(7):3800\u20137. https:\/\/doi.org\/10.1245\/s10434-020-09446-x.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2348_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s44276-023-00028-4","volume":"2","author":"C Morizane","year":"2024","unstructured":"Morizane C, Ueno M, Ikeda M, et al. A phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer. BJC Rep. 2024;2(1):3. https:\/\/doi.org\/10.1038\/s44276-023-00028-4.","journal-title":"BJC Rep"},{"issue":"12","key":"2348_CR41","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200\u201310. https:\/\/doi.org\/10.1056\/NEJMoa032295.","journal-title":"N Engl J Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02348-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:57:40Z","timestamp":1779955060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02348-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2348"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02348-x","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All human studies were approved by the appropriate ethics committees and were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The study was reviewed and approved by the Ethics Committee of Sun Yat-sen Memorial Hospital, Sun Yat-sen University (Approval ID: SYSKY-2023-1076-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}